CSPC Pharmaceutical Group (CVG) AI Stock Analysis

4 Followers

CSPC Pharmaceutical Group

(Frankfurt:CVG)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Very Low LeverageExtremely low leverage gives CSPC substantial financial flexibility and reduces interest and refinancing pressure. The conservative capital structure should help the company withstand operating volatility while preserving capacity to fund research, product development, and commercial expansion.

Negative Factors

Soft Revenue GrowthRecent revenue performance shows that CSPC’s top-line momentum has weakened materially from earlier periods. Declines followed by only low-single-digit growth can limit operating leverage, reduce resources available for reinvestment, and make future earnings more dependent on margin recovery or new products.

CSPC Pharmaceutical Group (CVG) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 12.77B
Dividend Yield: 3.82%
Average Volume (3M): 5,270
Price to Earnings (P/E): 11.2
Beta (1Y): 0.24
Revenue Growth: 16.37%
EPS Growth: 89.67%
Country: Germany
Employees: 18,626
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - General

CSPC Pharmaceutical Group Business Overview & Revenue Model

Company Description

CSPC Pharmaceutical Group Limited, primarily an investment holding entity, is dedicated to the development, production, and distribution of pharmaceutical goods. Its operations span the globe, with a significant presence in the People's Republic of C...

CSPC Pharmaceutical Group Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:CVG against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HK:3320	79Outperform	HKD 29.06B	6.11	7.92%	5.28%	7.94%	52.83%
HK:0867	61Neutral	HKD 25.71B	14.26	8.60%	3.31%	14.80%	-2.88%
HK:1177	61Neutral	HKD 98.92B	36.33	7.56%	2.17%	14.57%	-31.09%
HK:2607	58Neutral	HKD 64.25B	11.66	6.64%	5.93%	9.12%	-3.22%
HK:0874	57Neutral	HKD 35.45B	14.67	5.57%	6.73%	6.00%	-23.05%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

* Healthcare Sector Average

Performance Comparison

DE:CVG and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:CVG	CSPC Pharmaceutical Group	0.96	0.13	15.40%
HK:1177	Sino Biopharmaceutical	5.54	-1.66	-23.05%
HK:0867	China Medical System Holdings	10.39	-3.38	-24.57%
HK:0874	Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H	12.82	-6.27	-32.83%
HK:2607	Shanghai Pharmaceuticals Holding Co Class H	11.03	-0.65	-5.56%
HK:3320	China Resources Pharmaceutical Group Ltd.	4.54	-0.22	-4.64%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

CSPC Pharmaceutical Group AI Stock Analysis